Investigation of Subclinical Markers of Multiple Sclerosis
Recruiting · NCT04604041 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Split, School of Medicine
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Transcranial magnetic stimulation (TMS) studies reported consistent and substantial impairments in the central nervous system (CNS) in multiple sclerosis (MS). Studies of peripheral nervous system (PNS) function comprising electromyoneurography (EMNG) reported impairments of the PNS in MS that were less pronounced and inconsistent. Neurophysiological studies are generally small and cross-sectional and with the poor grouping of MS patients according to MS type. The objective of the study is to investigate clinical, neurophysiological, and immunological markers in relapsing-remitting MS patients, and in patients with relapsing-remitting MS treated with immunomodulation. The results of the study may contribute to a better understanding of the pathophysiology of multiple sclerosis and can provide guidance in the diagnosis and treatment of patients with relapsing-remitting MS.
Who can take part
Inclusion criteria
- Subjects with a documented diagnosis of relapsing-remitting MS according to the Mc Donald criteria (2005) and with EDSS achievement of 0-3.5 according to the modified Kurtzke's EDSS (Expanded disability status scale) for the assessment of neurological function and incapacity of patients with multiple sclerosis
Exclusion criteria
- Patients with metals in the body (e.g. pacemaker, dentures)
- Patients with new pregnancies (verbally confirmed)
- Patients with new head trauma
- Subjects unwilling to sign a consent or follow study procedures
Where it is running
1 location listed.
- University of Split School of Medicine - Split, Croatia